Michael Cherny
Stock Analyst at B of A Securities
(5.00)
# 10
Out of 4,814 analysts
131
Total ratings
55.1%
Success rate
104.02%
Average return
Main Sectors:
Stocks Rated by Michael Cherny
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MCK McKesson | Maintains: Buy | $665 → $755 | $697.08 | +8.31% | 12 | Apr 11, 2025 | |
| CAH Cardinal Health | Maintains: Buy | $150 → $155 | $134.68 | +15.09% | 11 | Apr 11, 2025 | |
| MEDP Medpace Holdings | Initiates: Market Perform | $330 | $296.28 | +11.38% | 1 | Mar 24, 2025 | |
| HIMS Hims & Hers Health | Maintains: Market Perform | $24 → $40 | $27.22 | +46.95% | 10 | Feb 25, 2025 | |
| CVS CVS Health | Upgrades: Outperform | $55 → $75 | $67.28 | +11.47% | 11 | Feb 13, 2025 | |
| PGNY Progyny | Maintains: Buy | $21 → $25 | $21.44 | +16.60% | 10 | Feb 11, 2025 | |
| DOCS Doximity | Upgrades: Outperform | $60 → $90 | $53.20 | +69.17% | 2 | Feb 7, 2025 | |
| ALGN Align Technology | Upgrades: Outperform | $235 → $280 | $171.41 | +63.35% | 2 | Jan 6, 2025 | |
| DGX Quest Diagnostics | Upgrades: Outperform | $135 → $174 | $163.77 | +6.25% | 2 | Jan 6, 2025 | |
| HSIC Henry Schein | Upgrades: Buy | $69 → $84 | $64.28 | +30.68% | 2 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $29 → $31 | $31.33 | +0.06% | 24 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $260 → $248 | $143.91 | +72.33% | 2 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $270 → $255 | $139.30 | +83.06% | 3 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $12.84 | - | 8 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | $16 → $23 | $15.19 | +51.42% | 10 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $277 → $275 | $286.94 | -4.16% | 3 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $25 | $1.42 | +1,660.56% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $23 → $22 | $10.80 | +103.70% | 2 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $260 | $217.06 | +19.79% | 1 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $23 | $19.45 | +15.68% | 5 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $8 | $4.48 | +78.77% | 5 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $19 | $14.15 | +34.28% | 1 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $17 | $6.83 | +148.90% | 1 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $113 → $53 | $11.27 | +365.84% | 2 | Jan 5, 2022 |
McKesson
Apr 11, 2025
Maintains: Buy
Price Target: $665 → $755
Current: $697.08
Upside: +8.31%
Cardinal Health
Apr 11, 2025
Maintains: Buy
Price Target: $150 → $155
Current: $134.68
Upside: +15.09%
Medpace Holdings
Mar 24, 2025
Initiates: Market Perform
Price Target: $330
Current: $296.28
Upside: +11.38%
Hims & Hers Health
Feb 25, 2025
Maintains: Market Perform
Price Target: $24 → $40
Current: $27.22
Upside: +46.95%
CVS Health
Feb 13, 2025
Upgrades: Outperform
Price Target: $55 → $75
Current: $67.28
Upside: +11.47%
Progyny
Feb 11, 2025
Maintains: Buy
Price Target: $21 → $25
Current: $21.44
Upside: +16.60%
Doximity
Feb 7, 2025
Upgrades: Outperform
Price Target: $60 → $90
Current: $53.20
Upside: +69.17%
Align Technology
Jan 6, 2025
Upgrades: Outperform
Price Target: $235 → $280
Current: $171.41
Upside: +63.35%
Quest Diagnostics
Jan 6, 2025
Upgrades: Outperform
Price Target: $135 → $174
Current: $163.77
Upside: +6.25%
Henry Schein
Jan 6, 2025
Upgrades: Buy
Price Target: $69 → $84
Current: $64.28
Upside: +30.68%
Dec 11, 2024
Downgrades: Market Perform
Price Target: $29 → $31
Current: $31.33
Upside: +0.06%
Nov 19, 2024
Reiterates: Outperform
Price Target: $260 → $248
Current: $143.91
Upside: +72.33%
Nov 19, 2024
Reiterates: Outperform
Price Target: $270 → $255
Current: $139.30
Upside: +83.06%
Nov 7, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $12.84
Upside: -
Oct 31, 2024
Upgrades: Market Perform
Price Target: $16 → $23
Current: $15.19
Upside: +51.42%
Oct 7, 2024
Maintains: Outperform
Price Target: $277 → $275
Current: $286.94
Upside: -4.16%
Apr 22, 2024
Initiates: Outperform
Price Target: $25
Current: $1.42
Upside: +1,660.56%
Mar 18, 2024
Maintains: Market Perform
Price Target: $23 → $22
Current: $10.80
Upside: +103.70%
Feb 26, 2024
Initiates: Outperform
Price Target: $260
Current: $217.06
Upside: +19.79%
Feb 26, 2024
Initiates: Market Perform
Price Target: $23
Current: $19.45
Upside: +15.68%
Feb 26, 2024
Initiates: Outperform
Price Target: $8
Current: $4.48
Upside: +78.77%
Feb 26, 2024
Initiates: Market Perform
Price Target: $19
Current: $14.15
Upside: +34.28%
Feb 26, 2024
Initiates: Market Perform
Price Target: $17
Current: $6.83
Upside: +148.90%
Jan 5, 2022
Downgrades: Underperform
Price Target: $113 → $53
Current: $11.27
Upside: +365.84%